GLOMERULAR BASEMENT MEMBRANE GBM ANTIBODY IgG Test
Cost: AED 470.0
Symptoms, Diagnosis, and Test Details
The Glomerular Basement Membrane (GBM) Antibody IgG test is a blood test used to detect the presence of antibodies against the glomerular basement membrane in the kidneys. The glomerular basement membrane is a component of the kidney’s filtration system, and the presence of these antibodies can indicate certain autoimmune diseases, such as Goodpasture syndrome.
In Goodpasture syndrome, the immune system mistakenly produces antibodies that attack the glomerular basement membrane, leading to inflammation and damage to the kidneys. This can result in symptoms such as blood in the urine, proteinuria (excessive protein in the urine), and kidney dysfunction.
The GBM Antibody IgG test is typically ordered if a person presents with symptoms suggestive of kidney disease, such as blood in the urine or kidney dysfunction. It can help confirm the diagnosis of Goodpasture syndrome or other conditions associated with glomerular basement membrane antibody production.
The test involves taking a blood sample, which is then sent to a laboratory for analysis. The presence of GBM antibodies is detected by measuring the levels of IgG antibodies specific to the glomerular basement membrane. A positive result indicates the presence of these antibodies and suggests a possible autoimmune kidney disease.
It is important to note that the GBM Antibody IgG test is just one part of the diagnostic process and should be interpreted in conjunction with other clinical findings and tests.
Test Components and Price
- Components: Glomerular Basement Membrane GBM Antibody IgG
- Price: AED 470.0
Sample Condition and Report Delivery
- Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen.
- Report Delivery: 1 week
Method and Test Type
- Method: Enzyme Immunoassay
- Test Type: Disorders of Kidney
Referring Doctor and Test Department
- Doctor: Nephrologist
- Test Department: Immunopathology
Pre Test Information
No special preparation required.
Treatment and Conclusion
Treatment for Goodpasture syndrome typically involves immunosuppressive medications to suppress the immune response and reduce kidney damage.
In conclusion, the Glomerular Basement Membrane GBM Antibody IgG test is an important diagnostic tool for identifying autoimmune kidney diseases such as Goodpasture syndrome. It is a simple blood test that can help confirm the presence of antibodies against the glomerular basement membrane and aid in the diagnosis and treatment of kidney disorders.
| Test Name | GLOMERULAR BASEMENT MEMBRANE GBM ANTIBODY IgG Test |
|---|---|
| Components | |
| Price | 470.0 AED |
| Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. |
| Report Delivery | 1 week |
| Method | Enzyme Immunoassay |
| Test type | Disorders of Kidney |
| Doctor | Nephrologist |
| Test Department: | IMMUNOPATHOLOGY |
| Pre Test Information | No special preparation required |
| Test Details |
The Glomerular Basement Membrane (GBM) Antibody IgG test is a blood test used to detect the presence of antibodies against the glomerular basement membrane in the kidneys. The glomerular basement membrane is a component of the kidney’s filtration system, and the presence of these antibodies can indicate certain autoimmune diseases, such as Goodpasture syndrome. In Goodpasture syndrome, the immune system mistakenly produces antibodies that attack the glomerular basement membrane, leading to inflammation and damage to the kidneys. This can result in symptoms such as blood in the urine, proteinuria (excessive protein in the urine), and kidney dysfunction. The GBM Antibody IgG test is typically ordered if a person presents with symptoms suggestive of kidney disease, such as blood in the urine or kidney dysfunction. It can help confirm the diagnosis of Goodpasture syndrome or other conditions associated with glomerular basement membrane antibody production. The test involves taking a blood sample, which is then sent to a laboratory for analysis. The presence of GBM antibodies is detected by measuring the levels of IgG antibodies specific to the glomerular basement membrane. A positive result indicates the presence of these antibodies and suggests a possible autoimmune kidney disease. It is important to note that the GBM Antibody IgG test is just one part of the diagnostic process and should be interpreted in conjunction with other clinical findings and tests. Treatment for Goodpasture syndrome typically involves immunosuppressive medications to suppress the immune response and reduce kidney damage. |
